Loading...
Back to narrative

ENVX: Mobile Ramp Delays Will Ultimately Unlock Long Term Upside Potential

Update shared on 18 Dec 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-19.2%
7D
-9.0%

Analysts have reduced their price target on Enovix by $9, to $16 from $25. They cite a slower than expected ramp in mobile phone revenues and the view that current 2026 consensus estimates remain overly optimistic.

Analyst Commentary

Bullish analysts maintain a constructive long term view on Enovix, emphasizing that the recent price target cut still implies meaningful upside from current levels.

Bullish Takeaways

  • Outperform ratings are being maintained, indicating confidence that the recent reset in expectations better aligns the stock with achievable execution milestones.
  • The more than $500M raised in Q3 provides a substantial liquidity cushion to fund capacity expansion and support the mobile ramp, which underpins long term growth potential.
  • The revised 2026 projections are now closer to the low end of Street expectations, which some see as de risked and supportive of a more reliable valuation framework.
  • Analysts view Enovix's differentiated battery technology as intact, suggesting that once production and customer qualification hurdles are addressed, earnings power could inflect rapidly.

Bearish Takeaways

  • Bearish analysts view the slower than expected mobile phone revenue ramp as evidence of ongoing execution risk, raising doubts about the timing of scale and margin leverage.
  • The significant cut in the price target, and positioning estimates at the Street low for 2026, highlights concern that prior growth assumptions were overly aggressive.
  • There is increasing skepticism that current 2026 consensus forecasts accurately reflect commercialization risk, potentially leaving room for further estimate and multiple compression.
  • The contrast between the large capital raise and the delayed revenue ramp fuels worries about capital efficiency and the risk of extended periods of negative free cash flow.

What's in the News

  • Issued fourth quarter 2025 revenue guidance of $9.5 million to $10.5 million, indicating initial expectations for next year's mobile and customer ramps (company guidance).
  • Completed a share repurchase tranche totaling 5,437,556 shares, or 2.82% of shares outstanding, for $58.29 million under the buyback program announced July 2, 2025 (company filing).

Valuation Changes

  • Fair Value: Unchanged at $26.90, indicating no shift in the long term intrinsic value assessment.
  • Discount Rate: Risen slightly from 10.06% to 10.08%, reflecting a marginal increase in perceived risk or required return.
  • Revenue Growth: Effectively unchanged at approximately 166.64%, signaling a stable outlook for top line expansion assumptions.
  • Net Profit Margin: Remains essentially flat at about 20.51%, suggesting no material revision to long term profitability expectations.
  • Future P/E: Increased very slightly from 78.30x to 78.35x, implying a minimal upward adjustment in the valuation multiple applied to future earnings.

Have other thoughts on Enovix?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.